FindTrial
Sign In

Thromboelastography and conventional coagulation test in detecting antiplatelet agents after endovascular treatments in acute ischemic stroke patients

Endovascular treatments and antiplatelet agents applying in acute ischemic stroke patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018522
Enrollment
Unknown
Registered
2018-09-21
Start date
2018-09-30
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke patients

Interventions

Gold Standard:conventional coagulation test
Index test:prothrombin&#32
time&#32
(PT,&#32
seconds),&#32
activated&#32
partial&#32
thromboplastin&#32
(APTT,&#32
fibrinogen&#32
(FIB,&#32
g/L),&#32
international&#32
normalized&#32
ratio&#32
(INR),&#32
and&#32
platelets&#32

Sponsors

the P.L.A Army General Hospita
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 80 years old; 2. Diagnosed acute ischemic stroke by using brain computed tomography (CT), diffuse weighted magnetic resonance imaging (MRI) and/or magnetic resonance angiography (MRA); 3. Unimproved clinical symptoms with 1 h after strict intravenous thrombolysis (NIHSS score improved less than 4). Time since stroke onset beyond 4.5 h, but less than 8 h for anterior circulation and less than 24 h for posterior circulation. Or, contraindication of intravenous thrombolysis even within the intravenous thrombolysis time window (4.5 h); 4. Using arterial thrombectomy, balloon stents for treatment and antiplatelet agents.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
R, K, a angle, MA;—

Countries

China

Contacts

Public ContactYang Yang

Army General Hospital of Beijing

yang.yang@usz.ch+86 417 87405866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026